Turkish Hedge Fund Manager Okumus Is Betting On Valeant Pharmaceuticals International, Web.com, Lifelock

The decline in Valeant Pharmaceuticals International (NYSE:VRX) is starting to attract value investors to the stock.

Keep Reading →